Friday, March 29, 2019

Delay dementia-Study shows how

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Watch: How Alzheimer's Changes the Brain


University of Texas Health Science Center at San Antonio

PROGRESS: A key study shows an easing, in certain respects, of the harsh impact of dementia. On average, people seem to be developing dementia later in life. This means more healthy years and fewer painful ones. 




An important study, included in a special supplement to the Journal of Gerontology, indicates that dementia's impact might be compressing a bit. That is, people might be developing dementia later and living with it for a shorter period of time.

More Years in Health, Fewer Years in Dementia

Faster than the lengthening of our lifespans, has been the increase in dementia-free years. That means people continue to live longer. On top of that, more and more of those years are spent free of dementia. 

Sudha Seshadri, M.D., professor of neurology and founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, is the senior author on the study, which draws evidence from the Framingham Heart Study. 

In data from four different time periods over a period of 30 years, the mean age at dementia onset increased, while the length of time living with dementia decreased.

Improvements in Stroke Treatment Lowers Dementia

Is it because prevention and care of stroke today is superior compared to decades ago? Stroke is a major risk factor for dementia. 

"Prevention of stroke and reduced impact of stroke are great advances, but neither completely explains the trend we are seeing," Dr. Seshadri said. "We are looking at other causes, such as:

  1. Lower burden of multiple infections because of vaccination, and
  2. Possibly lower levels of lead or other pollutants in the atmosphere.
  3. Early education and nutrition might also play a role."
Stroke risk has decreased because of greater control of blood pressure. Dr. Seshadri again cited Framingham data: "In the past, if you had a stroke you were at 90 percent greater risk to develop dementia. Today, you have a 40 percent greater risk," she said. 


REFERENCE:

SOURCE:

Tuesday, March 26, 2019

Dementia professionals-Top tips for you

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two



Saturday, March 23, 2019

Reduce side effects of Alzheimer's drugs

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two




Learn the best ways to dose Alzheimer's medications. See how anti-dementia drugs like Exelon®(rivastigmine) help treat Alzheimer's symptoms. 




An important study shows anti-Alzheimer's capsulesare better tolerated when spread out over a three-times-a-day regimen. Similarly, anti-Alzheimer's skin-patches can lower side-effects by slowly releasing medication throughout the day. 

The study used the dementia drug known by the brand-name Exelon®, or generically as rivastigmine. Exelon is an "acetylcholinesterase inhibitor", as are Aricept (donepezil) and Razadyne (galantamine). They all treat dementias such as Alzheimer's in very similar ways. They also share similar side-effects. 

Continued below video...


Exelon® (rivastigmine) is one of the most common medications prescribed for people with mild to moderate Alzheimer's disease.

Alzheimer's disease is caused by degeneration of the nerve cells that produce acetylcholine. Because of this, preventing loss of this chemical by taking Exelon® may improve a person's memory, the ability to express himself, understand where he or she is, and to carry out his daily living activities.

Exelon® slows down Alzheimer’s cognitive decline by preventing the loss of a brain chemical called acetylcholine. Acetylcholine is important for memory and learning.

These 3 Alzheimer's drugs are similar, working as Acetylcholinesterase Inhibitors:
Brand NameGeneric
Exelonrivastigmine
Ariceptdonepezil
Razadynegalantamine
It has been more than 10 years since Exelon® first came out on the market. It is now used to treat Alzheimer's disease in more than 70 countries around the world. It is approved by the Food and Drug Administration (FDA) for treatment of Alzheimer's and Parkinson's disease dementia in the United States as well as by the European Commission in Europe.

There are several different forms of Exelon® and a number of different doses, making it easier and safer to take, including gel capsules, liquid and through a skin patch.

As mentioned, a study published in the Journal of Neurology, Neurosurgery and Psychiatry found that Exelon® capsules were best tolerated when prescribed in a three-times-a-day regimen, instead of twice a day. According to the principle investigator, Dr. Howard H. Feldman, the overall daily dose remained the same, but was divided into three smaller doses, distributed evenly throughout the day. This reduced side effects because the dosage-spike was lower when the level of medication swallowed at one time was lower.

For people who can't swallow pills, Exelon® is available in liquid form. Many elderly people have trouble swallowing pills and they often fight with caregivers over having to take the medication as a result. Liquid is less threatening.

Exelon® is also available in a skin patch, which makes it easier on the patient and the caregiver because it eliminates the need to make sure the liquid or pills are swallowed on time, three times a day. Instead, the medication is absorbed directly from the patch through the skin and into the bloodstream, where it is supplied continually for 24 hours. It only needs to be changed at the beginning of each day, which is a great convenience.

An even more important advantage is in the patch providing a visual reassurance for the caregiver and patient that the patient is receiving their medication.

Exelon® is also available as generic rivastigmine. Typically, the generic is cheaper than the brand name, Exelon®, while being the same medication. This is especially important for the elderly, where income often becomes more limited.

One producer of generic rivastigmine capsules is Sun Pharmaceutical Industries, a specialty pharmaceutical company located in India which distributes advanced generic medicines in the United States. Their generic version of Exelon® come in four strengths: 1.5 mg, 3 mg, 4.5 mg and 6 mg.


Thursday, March 21, 2019

Song that inspires those with Alzheimer's, their families and others

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Jay Allen

Raising 20 million dollars for Alzheimer's, Jay Allen found the courage to write a song about the journey in caring for his mom's Alzheimer's. The song is called "Blank Stares". His vision is that this song will raise awareness, bring hope to those affected, and most importantly, become a weapon in the fight against Alzheimer's. 




My name is Jay Allen. I'm a country music artist and songwriter signed to Sony/ATV in Nashville, TN. 


My mom has early onset Alzheimer's, and at the age of only 52, she's now showing signs of stage 6. It's something that has affected my family deeply, something that we can't escape, and it brings me to my knees most days. 

Print Friendly Version of this pagePrint Get a PDF version of this webpagePDFI grew up in small town rural Iowa with mom(Sherry), dad(Joe), and my two baby sisters(Cassie and Amber). We didn't have a lot, but our parents always seemed to find a way, sometimes working 2-3 jobs each to make sure we had enough. Looking back, it was a humbling childhood, but what I think affected me most was my mother's affection and selflessness towards all of us. She always put her children first, no matter what the sacrifice. If we wanted some stupid toy for Christmas, she would work the overtime or pick up an extra shift. She didn't care what it took, she just wanted us to be happy. 

When I was in middle school, I remember asking my mom what she would change to make her life better if she could go back in time. 


Her response was, "I wouldn't change a thing. I was made to be a good mom. I live for you kids." 

Now that I'm older, I hold onto those words as I watch this horrible disease steal away a beautiful woman. Sometimes I want to yell at God when I hear her stumble through a simple sentence, or when I look at her and feel like she's not even there anymore. It makes me so mad, and it kills me that I can't fix it. But then there are the moments of hope, when dad brings her to visit Nashville and we dance all night at The Sutler…or when she grins and taps her foot to the live music…or when I wrap my arms around her, and she takes a deep breath and says, "I've missed you, Jay." 

Her words, the good memories, and the moments of joy - that's what I hold onto. 

As a songwriter and up-and-coming artist, I feel that I have an obligation to be a positive role-model, and to also give back by utilizing the gifts that God has blessed me with. In realizing the importance of this, I finally found the courage to write a song about my experience, called "Blank Stares". My vision is that this song will raise awareness, bring hope to those affected, and most importantly, become a weapon in the fight against Alzheimer's. 

So please, download your copy of "Blank Stares" today, share, and dream with me. Music is powerful. Let's do something with it. 

With all my heart,
Jay Allen 

Tuesday, March 19, 2019

Why high sugar increases dementia risk>

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Group Health Research Institute.

Dementia risks for 17 sugar levels were tested in 2000 people. Without exception, each higher level bumped up the risk. See why researchers found these results so astonishing. 




A joint Group Health-University of Washington (UW) study in the New England Journal of Medicine has found that higher blood sugar levels are associated with higher dementia risk, even among people who do not have diabetes. (Continued below video.)

Continued below video...


Blood sugar levels averaged over a five-year period were associated with rising risks for developing dementia, in this report about more than 2,000 Group Health patients age 65 and older in the Adult Changes in Thought (ACT) study.

There was No Level Where Risk Leveled Off

For example, in people without diabetes, risk for dementia was 18 percent higher for people with an average glucose level of 115 milligrams per deciliter compared to those with an average glucose level of 100 mg/dl. And in people with diabetes, whose blood sugar levels are generally higher, dementia risk was 40 percent higher for people with an average glucose level of 190 mg/dl compared to those with an average glucose level of 160 mg/dl.

"The most interesting finding was that every incrementally higher glucose level was associated with a higher risk of dementia in people who did not have diabetes," said first author Paul K. Crane, MD, MPH, an associate professor of medicine at the UW School of Medicine, adjunct associate professor of health services at the UW School of Public Health, and affiliate investigator at Group Health Research Institute. "There was no threshold value for lower glucose values where risk leveled off."

Very Rich Data

"One major strength of this research is that it is based on the ACT study, a longitudinal cohort study, where we follow people for many years as they lead their lives," said senior author Eric B. Larson, MD, MPH, a senior investigator at Group Health Research Institute who also has appointments at the UW Schools of Medicine and Public Health. "We combine information from people's research visits every other year with data from their visits to Group Health providers whenever they receive care. And this gave us an average of 17 blood sugar measurements per person: very rich data."

These measurements included blood glucose (some fasting, some not) and glycated hemoglobin (also known as HbA1c). Blood sugar levels rise and fall in peaks and valleys throughout each day, but glycated hemoglobin doesn't vary as much over short intervals.

Sophisticated Statistical Models

Combining glucose and glycated hemoglobin measures into a composite measure required special statistical techniques, which Drs. Crane and Larson's co-authors Rod Walker, MS, a biostatistician, and Rebecca Hubbard, PhD, an associate investigator, both from Group Health Research Institute, had developed. (Dr. Hubbard is also an affiliate assistant professor of biostatistics at the UW School of Public Health.) These sophisticated statistical models required specialized data on the relationships between glycated hemoglobin and glucose levels, and they used data generated by co-author David M. Nathan, MD, a professor of medicine at Harvard Medical School and director of the Diabetes Center at Massachusetts General Hospital.

So should people try to eat less sugar -- or foods with a lower "glycemic index"? Not necessarily, Dr. Crane said: "Your body turns your food into glucose, so your blood sugar levels depend not only on what you eat but also on your individual metabolism: how your body handles your food." But he does suggest that taking walks couldn't hurt: The ACT study has previously linked physical activity to later onset and reduced risk of dementia, including Alzheimer's disease.

Furthermore, Dr. Crane emphasized that these results come from an observational study: "What we found was that people with higher levels of glucose had a higher risk of dementia, on average, than did people with lower levels of glucose," he said. "While that is interesting and important, we have no data to suggest that people who make changes to lower their glucose improve their dementia risk. Those data would have to come from future studies with different study designs."

Sunday, March 17, 2019

Why exercise to prevent Alzheimer's?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


http://brainandmemoryfoundation.org. 


This is a great way to get a simple yet complete workout in just 5 minutes a day. 

Why use Workout Exercises for Fitness?

  • This best fitness workout plan isn't strenuous
  • You don't need special clothes
  • The keep-fit exercises are a great wake-up for your brain
  • And the fitness workout is suitable for all ages -- and fantastic for the over-50's!
This program seems simple -- and it is. But the series of fitness exercises is designed to get each of the major muscle groups engaged and active -- just what you need for a fitness workout that will keep you fit for life. It isn't a weight loss program but it will give you the energy to start on that if that is what you are looking for.

Try it even if you are not as active now as you once were. Life experiences differ and some folk can't do the standing parts anymore. Well, no worries -- just do the arm exercises and most of the leg exercises sitting down. You are still achieving a lot and you will feel much better for the few minutes spent on these exercises for fitness. You can even do the 'lying down' ones in bed!

You don't have to accept memory loss as a way of life! Exercise is a key factor in brain health. Want to see some solid research showing how exercise improves memory? Go to the "Pick a Topic" box in the right column and click on "Exercise". 

If you prefer a written copy of the Workout Exercises for Fitness, go to http://brainandmemoryfoundation.org. 

The Brain and Memory Foundation was established by Dr. Allison Lamont and Gillian Eadie to help the over-50 age group build more brain connections as a buffer against dementia and Alzheimer's disease. 

Wednesday, March 13, 2019

How many sub types of Alzheimer's are there?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


UCLA, University of California at Los Angeles

Until now, Alzheimer's was thought to be a single disease. Advanced research is redefining Alzheimer's, showing three distinct subtypes. Find out the differences. 




Alzheimer's disease, long thought to be a single disease, really consists of three distinct subtypes, according to a UCLA study.

The finding could lead to more highly targeted research and, eventually, new treatments for the debilitating neurological disorder, which robs people of their memories.

The study further found that one of the three variations, the cortical subtype, appears to be fundamentally a different condition than the other two, said Dr. Dale Bredesen, the study's author, a UCLA professor of neurology and member of the Easton Laboratory for Neurodegenerative Disease Research.

"Because the presentation varies from person to person, there has been suspicion for years that Alzheimer's represents more than one illness," said Bredesen, who also is the founding president of the Buck Institute for Research on Aging. "When laboratory tests go beyond the usual tests, we find these three distinct subtypes.

"The important implications of this are that the optimal treatment may be different for each group, there may be different causes, and, for future clinical trials, it may be helpful to study specific groups separately."

The subtypes are:

  1. Inflammatory, in which markers such as C-reactive protein and serum albumin to globulin ratios are increased.
  2. Non-inflammatory, in which these markers are not increased but other metabolic abnormalities are present.
  3. Cortical, which affects relatively young individuals and appears more widely distributed across the brain than the other subtypes of Alzheimer's. It typically does not seem to cause memory loss at first, but people with this subtype of the disease tend to lose language skills. It is often misdiagnosed, typically affects people who do not have an Alzheimer's-related gene and is associated with a significant zinc deficiency.
The findings of the two-year study, which involved metabolic testing of 50 people, appear in the current issue of the peer-reviewed journal Aging.

No effective therapy for Alzheimer's exists. And scientists have yet to completely identify the cause, although multiple studies have pointed to metabolic abnormalities such as insulin resistance, hormonal deficiencies and hyperhomocysteinemia, a condition characterized by an abnormally high level of an amino acid in the blood.

In an earlier paper, Bredesen showed that making lifestyle, exercise and diet changes designed to improve the body's metabolism reversed cognitive decline in nine out of 10 patients with early Alzheimer's disease or its precursors.

The current finding grew out of an extensive evaluation of the data from last year's study, and it could eventually help scientists pinpoint more precise targets for treatments -- the same approach that has led to major advances in treating other diseases.

For example, Bredesen explained, researchers have recently been able to develop precise treatments for cancer by sequencing tumor genomes and comparing them to the patients' genomes to better understand what drives the formation and growth of tumors.

"However, in Alzheimer's disease, there is no tumor to biopsy," Bredesen said. "So how do we get an idea about what is driving the process? The approach we took was to use the underlying metabolic mechanisms of the disease process to guide the establishment of an extensive set of laboratory tests, such as fasting insulin, copper-to-zinc ratio and dozens of others."

Going forward, Bredesen and his team will seek to determine whether the subtypes have different underlying causes, and whether they respond differently to potential treatments.

The need for a new approach to treat Alzheimer's is urgent. It is the most common age-related dementia, and the number of people with the disease in the U.S. is expected to increase to 15 million in 2050, from nearly 6 million today. The cost to treat people in the U.S. with Alzheimer's and other dementias is expected to be $226 billion in 2015 alone, and could reach $1.1 trillion in 2050. 
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info